[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:her2-low-breast-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"HER2-Low Breast Carcinoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05795101","TRUDI: TDXD+Durva in HER2+\u002FLow IBC",[11],"Phase 2","RECRUITING","2026-08-26T02:18:14.396999Z","2026-05-05T02:43:28.656877Z",[],[]]